171 related articles for article (PubMed ID: 29651245)
1. Antiseptic Activity of Ethnomedicinal Xuebijing Revealed by the Metabolomics Analysis Using UHPLC-Q-Orbitrap HRMS.
Zuo L; Zhou L; Xu T; Li Z; Liu L; Shi Y; Kang J; Gao G; Du S; Sun Z; Zhang X
Front Pharmacol; 2018; 9():300. PubMed ID: 29651245
[TBL] [Abstract][Full Text] [Related]
2. Metabolomics approach in lung tissue of septic rats and the interventional effects of Xuebijing injection using UHPLC-Q-Orbitrap-HRMS.
Xu T; Zhou L; Shi Y; Liu L; Zuo L; Jia Q; Du S; Kang J; Zhang X; Sun Z
J Biochem; 2018 Dec; 164(6):427-435. PubMed ID: 30165618
[TBL] [Abstract][Full Text] [Related]
3. UHPLC-Q-TOF MS-Based Metabolic Analysis for the Therapeutic Efficacy of "Xuebijing Injection" against Sepsis-Induced Acute Lung Injury.
Shi X; Chen G; Wei J; Feng D; Chen Y; Zhou H; Liu M; Lv X
Evid Based Complement Alternat Med; 2018; 2018():8514619. PubMed ID: 30344613
[TBL] [Abstract][Full Text] [Related]
4. Simultaneous determination and pharmacokinetic study of twelve bioactive compounds in rat plasma after intravenous administration of Xuebijing injection by UHPLC-Q-Orbitrap HRMS.
Zuo L; Zhong Q; Wang Z; Sun Z; Zhou L; Li Z; Xu T; Shi Y; Tang J; Du S; Zhang X
J Pharm Biomed Anal; 2017 Nov; 146():347-353. PubMed ID: 28918324
[TBL] [Abstract][Full Text] [Related]
5. GC/MS-based metabonomics approach reveals effects of Xuebijing injection in CLP induced septic rats.
Jiang Y; Zou L; Liu S; Liu X; Chen F; Liu X; Zhu Y
Biomed Pharmacother; 2019 Sep; 117():109163. PubMed ID: 31238257
[TBL] [Abstract][Full Text] [Related]
6. [Positive effects of Xuebijing injection on intestinal microbiota and metabolite spectrum in septic rats].
Ding X; Yuan Y; Tong R; Wang K; Liu S; Qi X; Zhang X; Cao J; Sun T
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2023 Jul; 35(7):690-695. PubMed ID: 37545444
[TBL] [Abstract][Full Text] [Related]
7. Metabolomic Insights Into the Synergistic Effect of Biapenem in Combination With Xuebijing Injection Against Sepsis.
Liu LW; Shi YY; Li ZL; Zuo LH; Tang M; Jing ZW; Zhao HY; Xue P; Zhou L; Du QZ; Zhang XJ; Sun Z
Front Pharmacol; 2020; 11():502. PubMed ID: 32390846
[TBL] [Abstract][Full Text] [Related]
8. Exploring the potential mechanism of Xuebijing injection against sepsis based on metabolomics and network pharmacology.
Chen F; Yan S; Xu J; Jiang Y; Wang J; Deng H; Wang J; Zou L; Liu Y; Zhu Y
Anal Biochem; 2023 Dec; 682():115332. PubMed ID: 37816419
[TBL] [Abstract][Full Text] [Related]
9. Discovery of Xuebijing Injection Exhibiting Protective Efficacy on Sepsis by Inhibiting the Expression of HMGB1 in Septic Rat Model Designed by Cecal Ligation and Puncture.
Chen S; Dai G; Hu J; Rong A; Lv J; Su L; Wu X
Am J Ther; 2016; 23(6):e1819-e1825. PubMed ID: 26313171
[TBL] [Abstract][Full Text] [Related]
10. Anti-sepsis protection of Xuebijing injection is mediated by differential regulation of pro- and anti-inflammatory Th17 and T regulatory cells in a murine model of polymicrobial sepsis.
Chen X; Feng Y; Shen X; Pan G; Fan G; Gao X; Han J; Zhu Y
J Ethnopharmacol; 2018 Jan; 211():358-365. PubMed ID: 28987599
[TBL] [Abstract][Full Text] [Related]
11. Rapid determination of 30 bioactive constituents in XueBiJing injection using ultra high performance liquid chromatography-high resolution hybrid quadrupole-orbitrap mass spectrometry coupled with principal component analysis.
Zuo L; Sun Z; Hu Y; Sun Y; Xue W; Zhou L; Zhang J; Bao X; Zhu Z; Suo G; Zhang X
J Pharm Biomed Anal; 2017 Apr; 137():220-228. PubMed ID: 28147306
[TBL] [Abstract][Full Text] [Related]
12. Identification of NF-κB Inhibitors in Xuebijing injection for sepsis treatment based on bioactivity-integrated UPLC-Q/TOF.
Jiang M; Zhou M; Han Y; Xing L; Zhao H; Dong L; Bai G; Luo G
J Ethnopharmacol; 2013 May; 147(2):426-33. PubMed ID: 23524166
[TBL] [Abstract][Full Text] [Related]
13. Xuebijing Injection () and Resolvin D1 Synergize Regulate Leukocyte Adhesion and Improve Survival Rate in Mice with Sepsis-Induced Lung Injury.
Zhang SK; Zhuo YZ; Li CX; Yang L; Gao HW; Wang XM
Chin J Integr Med; 2018 Apr; 24(4):272-277. PubMed ID: 28497397
[TBL] [Abstract][Full Text] [Related]
14. Chemical profiling and quantification of XueBiJing injection, a systematic quality control strategy using UHPLC-Q Exactive hybrid quadrupole-orbitrap high-resolution mass spectrometry.
Sun Z; Zuo L; Sun T; Tang J; Ding D; Zhou L; Kang J; Zhang X
Sci Rep; 2017 Dec; 7(1):16921. PubMed ID: 29208914
[TBL] [Abstract][Full Text] [Related]
15. Xuebijing exerts protective effects on lung permeability leakage and lung injury by upregulating Toll-interacting protein expression in rats with sepsis.
Liu MW; Wang YH; Qian CY; Li H
Int J Mol Med; 2014 Dec; 34(6):1492-504. PubMed ID: 25269519
[TBL] [Abstract][Full Text] [Related]
16. Integrated metabolomic analysis for intervention effects of Gushudan on glucocorticoid-induced osteoporostic rat plasma based on RP/HILIC-UHPLC-Q-Orbitrap HRMS.
Yuan X; Wen J; Jia H; Tong L; Zhao J; Zhao L; Xiong Z
Anal Biochem; 2020 Feb; 591():113559. PubMed ID: 31874173
[TBL] [Abstract][Full Text] [Related]
17. [Effects of Xuebijing on hypothalamus-pituitary-adrenal axis in early stage of septic rats].
Zhang Y; Li H; Ma P
Zhonghua Yi Xue Za Zhi; 2014 Aug; 94(32):2549-52. PubMed ID: 25410931
[TBL] [Abstract][Full Text] [Related]
18. [Plasma metabolomics in a deep vein thrombosis rat model based on ultra-high performance liquid chromatography-electrostatic field orbitrap high resolution mass spectrometry].
Gu Y; Zang P; Li J; Yan Y; Wang J
Se Pu; 2022 Aug; 40(8):736-745. PubMed ID: 35903841
[TBL] [Abstract][Full Text] [Related]
19. The current evidence for the treatment of sepsis with Xuebijing injection: Bioactive constituents, findings of clinical studies and potential mechanisms.
Li C; Wang P; Li M; Zheng R; Chen S; Liu S; Feng Z; Yao Y; Shang H
J Ethnopharmacol; 2021 Jan; 265():113301. PubMed ID: 32860891
[TBL] [Abstract][Full Text] [Related]
20. [To explore the preventive and therapeutic effects of Xuebijing injection on acute lung injury induced by cardiopulmonary bypass in rats by regulating the expression of microRNA-17-5p and its mechanism].
Xu Z; Liu D; Li K; Li X; Song L
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2019 Jul; 31(7):867-872. PubMed ID: 31441412
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
